C07K 14/005
From viruses
Official title: from viruses
C07K14/005 (From viruses) appears on 10,803 US grants and 13,406 published applications in this corpus.
Search patents in C07K- Granted patents
- 10,803
- Published applications
- 13,406
- Assignees
- 4,459
- Inventors
- 22,474
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 5 | 0 |
| 1977 | 4 | 0 |
| 1978 | 11 | 0 |
| 1979 | 6 | 0 |
| 1980 | 10 | 0 |
| 1981 | 3 | 0 |
| 1982 | 8 | 0 |
| 1983 | 5 | 0 |
| 1984 | 6 | 0 |
| 1985 | 10 | 0 |
| 1986 | 21 | 0 |
| 1987 | 34 | 0 |
| 1988 | 50 | 0 |
| 1989 | 60 | 0 |
| 1990 | 37 | 0 |
| 1991 | 73 | 0 |
| 1992 | 103 | 0 |
| 1993 | 99 | 0 |
| 1994 | 104 | 0 |
| 1995 | 116 | 0 |
| 1996 | 171 | 0 |
| 1997 | 315 | 0 |
| 1998 | 489 | 0 |
| 1999 | 417 | 0 |
| 2000 | 415 | 0 |
| 2001 | 386 | 65 |
| 2002 | 314 | 386 |
| 2003 | 333 | 626 |
| 2004 | 239 | 550 |
| 2005 | 197 | 527 |
| 2006 | 275 | 477 |
| 2007 | 276 | 396 |
| 2008 | 266 | 414 |
| 2009 | 281 | 491 |
| 2010 | 298 | 544 |
| 2011 | 264 | 500 |
| 2012 | 284 | 387 |
| 2013 | 247 | 377 |
| 2014 | 357 | 473 |
| 2015 | 324 | 424 |
| 2016 | 316 | 431 |
| 2017 | 370 | 427 |
| 2018 | 386 | 451 |
| 2019 | 383 | 544 |
| 2020 | 355 | 508 |
| 2021 | 367 | 661 |
| 2022 | 358 | 673 |
| 2023 | 341 | 829 |
| 2024 | 389 | 899 |
| 2025 | 381 | 780 |
| 2026 | 244 | 566 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Mutant influenza B/Victoria lineage virus hemagglutinin proteins6 Oct 2026US 12,752,001 B2ModernaTX, Inc.
- Polypeptides, compositions, and their use to treat or limit development of an infection6 Oct 2026US 12,752,002 B2University of Washington
- Antiviral structurally-stabilized Ebolavirus peptides and uses thereof6 Oct 2026US 12,753,208 B2Dana-Farber Cancer Institute, Inc.
- Methods and compositions for promoting survival and proliferation of endothelial cells and stimulating angiogenesis6 Oct 2026US 12,753,384 B2Cornell Research Foundation, Inc.
- Immortalized keratinocytes, lentivirus for keratinocyte immortalization, and methods of use6 Oct 2026US 12,753,388 B2Regents of the University of Minnesota
- Vaccines against african swine fever virus, and methods of using same8 Oct 2026US 2026/0306608 A1The Wistar Institute of Anatomy and Biology
- Influenza estem immunogens8 Oct 2026US 2026/0306612 A1
- Prefusion-stabilized human parainfluenza virus 3 f proteins8 Oct 2026US 2026/0306613 A1Board of Regents, The University of Texas System
- Spike Protein Based Genetic Vaccines8 Oct 2026US 2026/0306616 A1University of Maryland, Baltimore
- Dengue virus serotype-specific modulation of t cell responses8 Oct 2026US 2026/0306621 A1The United States Government as represented by the Department of Veterans Affairs
Most cited
By later US patents
- Immunizing compositions comprising nucleic acids encoding the HIV-1 matrix protein myristate binding site1,449US 7,718,180 B22010
- Promoter (FLt) for the full-length transcript of peanut chlorotic streak caulimovirus (PCLSV) and expression of chimeric genes in plants1,256US 5,850,019 AUniversity of Kentucky Research Foundation · 1998
- Delivery of exogenous DNA sequences in a mammal1,218US 5,580,859 AVical Incorporated · 1996
- Induction of a protective immune response in a mammal by injecting a DNA sequence885US 5,589,466 AVical Incorporated · 1996
- Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity737US 4,554,101 ANew York Blood Center, Inc. · 1985